Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131)

The tumor tissue alteration of interest was detected in the plasma of 81% of patients who were enrolled in the NCI-MATCH trial based on central tissue testing and had contemporaneous tissue and plasma samples. This suggests a potential role for liquid biopsy in patient enrollment in trials evaluating biomarker-driven anticancer therapies. See related commentary by Russo et al., p. 4217.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-05-19
DOI
https://doi.org/10.1158/1078-0432.ccr-24-3531
Citations
3
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
2.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131)

Keyur P. Patel, Jeffrey Sklar, Ying Yuan, Lyndsay N. Harris et al.
3 citations
Clinical Cancer Research
Cancer Genomics and Diagnostics
2.81
article

Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131)

Keyur P. Patel, Jeffrey Sklar, Ying Yuan, Lyndsay N. Harris, Keith T. Flaherty, Peter James O'Dwyer, Carlos L. Arteaga, Alice P. Chen, Mark J. Routbort, Richard F. Little, A. John Iafrate, Leylah Drusbosky, Mohamed A. Gouda, Filip Jankú, Brent D. Coffey, Funda Meric‐Bernstam, Xiaofeng Zheng, James V. Tricoli, Stanley R. Hamilton, P. Mickey Williams
article en
3 citations

Abstract

The tumor tissue alteration of interest was detected in the plasma of 81% of patients who were enrolled in the NCI-MATCH trial based on central tissue testing and had contemporaneous tissue and plasma samples. This suggests a potential role for liquid biopsy in patient enrollment in trials evaluating biomarker-driven anticancer therapies. See related commentary by Russo et al., p. 4217.

Clinical Cancer ResearchVol. 31(20)
City Of Hope National Medical Center (US), The University of Texas MD Anderson Cancer Center (US), Yale University (US), University of New Haven (US), Massachusetts General Hospital (US), Guardant (United States) (US), City of Hope (US), Frederick National Laboratory for Cancer Research (US), National Cancer Institute (US), University of Pennsylvania (US), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Openalex Percentile: Top 10%
Cancer Genomics and Diagnostics
2.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.